Posted in Clinical Data IDEAYA/Servier PKC drug aces uveal melanoma trial April 13, 2026 Pharmaphorum Servier $210m bet on IDEAYA’s uveal melanoma therapy darovasertib seems to have paid off, as a trial sets up regulatory filings later in 2026. Clinical DataOncologyRead full story